Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
336 hedge funds and large institutions have $6.63B invested in Shockwave Medical, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 126 increasing their positions, 100 reducing their positions, and 35 closing their positions.
160% more call options, than puts
Call options by funds: $91.2M | Put options by funds: $35.1M
91% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 35
26% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 100
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
9% more funds holding
Funds holding: 308 → 336 (+28)
1% less capital invested
Capital invested by funds: $6.67B → $6.63B (-$42.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$283M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$111M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$72.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$71.7M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$50.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$156M |
| 2 |
Millennium Management
New York
|
-$87.9M |
| 3 |
Jennison Associates
New York
|
-$49.2M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$42.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$40.4M |
SWAV Hedge Fund Activity: Q2 2022 in Review
336 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q2 2022, worth a combined $6.63B — down 0.64% from $6.67B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new SWAV positions and 35 closed out — a net gain of 32 holders — while 126 added to existing stakes and 100 trimmed.
The largest buyer was BlackRock, adding an estimated $283M. The largest seller was Invesco, cutting an estimated $156M.
- 336 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q2 2022, up from 308 in Q1 2022.
- Funds reported $6.63B of Shockwave Medical, Inc. Common Stock stock for Q2 2022, down 0.64% quarter-over-quarter.
- 67 funds opened new Shockwave Medical, Inc. Common Stock positions in Q2 2022 and 35 closed out, a net change of +32 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q2 2022 was BlackRock, an estimated $283M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q2 2022 was Invesco, an estimated $156M sold.
Based on aggregated 13F filings for Q2 2022.